Dr. Trevor J Mcgill, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-8859 Fax: 617-730-0337 |
Hamdan Ahmed Pasha, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 330 Brookline Ave # Es-215, Boston, MA 02215 Phone: 617-667-3210 |
Richard V Grentzenberg, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 830 Harrison Avenue, Suite 1400, Boston, MA 02118 Phone: 617-638-8124 Fax: 617-638-6424 |
Dr. Steven Marc Zeitels, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Bowdoin Sq, 11th Floor, Boston, MA 02114 Phone: 617-726-1444 Fax: 617-726-0222 |
Dr. John M. Dobrowski, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-4104 Fax: 617-573-3914 |
Ralph A Iannuzzi, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 133 Brookline Ave, Boston, MA 02215 Phone: 617-421-5984 Fax: 617-421-2037 |
Pratima Agarwal, Otolaryngology Medicare: Medicare Enrolled Practice Location: 800 Harrison Avenue, Bcd 5th Floor, Boston, MA 02118 Phone: 617-638-7066 |
Robert Kiskaddon, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3431 |
Dr. Duane Bradley Welling, MD, PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900 |
Kevin Tie, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-632-9236 |
Heather Edwards, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 830 Harrison Ave Ste 1400, Boston, MA 02118 Phone: 617-638-8124 |
Donald G. Keamy Jr., M.D.,M.P.H. Otolaryngology Medicare: Medicare Enrolled Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3190 |
Dr. Ross Joseph O'shea, MD Otolaryngology - Pediatric Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-5064 Fax: 617-730-0611 |
Dr. Theresa A. Hadlock, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-4458 |
Brian Lin, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 110 Francis St Ste 9b, Boston, MA 02215 Phone: 617-632-9236 |
Dr. Gregory W. Randolph, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-4458 |
Andrew J Kleinberger, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 830 Harrison Ave, Suite 1400, Boston, MA 02118 Phone: 617-638-8124 |
Dr. Karen Fiona Watters, MD, MPH Otolaryngology Medicare: Medicare Enrolled Practice Location: 300 Longwood Avenue, Department Of Otolaryngology, Childrens Hospital Boston, Boston, MA 02215 Phone: 617-355-7793 |
Rotem Kimia, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 800 Washington St, Boston, MA 02111 Phone: 617-636-5891 |
Edward E Jacobs, M.D. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 243 Charles St, 9th Floor, Boston, MA 02114 Phone: 617-331-1541 |
News Archive
SRI International, an independent nonprofit research and development organization, announced today that it has assumed responsibility for further clinical development of the TAS-108 breast cancer program, in cooperation with Taiho Pharmaceuticals Co., Ltd., a leading Japanese pharmaceutical company. Further clinical development will focus on the lead compound's registration for the treatment of tamoxifen and aromatase inhibitor-resistant breast cancers.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of TCR engineered T-cell therapy to treat cancer, today announced a poster presentation of data on its lead clinical program, an affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen, in both solid and hematologic cancers.
Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.
Newborn babies who are diagnosed with and treated for jaundice are no more likely than other babies to suffer long-term developmental problems, according to a study published in the New England Journal of Medicine.
› Verified 8 days ago